Christopher Bell – Principal Analyst, Black Swan Analysis

With experience of a range of areas in the Healthcare Industry, Chris has worked with biotechs and pharma companies to produce forecasts, valuations and business support at both a regional, national and international level.

Chris has extensive experience in dealing with complex patient populations in a range of dynamic markets such as infectious disease, oncology, rare diseases and immunology. His background means that he has a considerable understanding in working with a wide range of data sources, such as primary and secondary data, to provide depth and segmentation when producing informative patient flow models.

He has the worked on forecasts in all phases of life cycle development including early phase drug discovery, asset valuations, business development and in-market support.
Chris holds a BSc Hons in biomedical science from the University of Surrey.

Alec Finney - MD, Forecast Insight

I am currently MD of Forecast Insight.  We believe that building a quality forecast model is essential to decision making. However - communicating that forecast to stakeholders with the context and insights that need is just as important, and we have developed tools to do just that.

From 2009 to 2015 I was Principal Consultant at Rivershill Consultancy, specialising in auditing business forecasting and planning forecasting systems and processes.

Before that I was Head of Global Forecasting at Astra Zeneca.

Greg Higgins - Analyst, Black Swan Analysis

Greg joined Black Swan Analysis in September 2017 as an Epidemiology Analyst after completing his BSc (Hons) in Pharmacology at the University of Southampton.

During his time with Black Swan, Greg has been involved in multiple client projects within the oncology arena including providing epidemiology data and review for an EMA submission in AML, and a competitive landscaping project analysing clinical trial data and performing company portfolio analyses. In addition, Greg has gained extensive disease domain knowledge in ophthalmology, neurological conditions (including schizophrenia) and a number of dermatological conditions.